Targeting cyclooxygenase-2 in depression is not a viable therapeutic approach and may even aggravate the pathophysiology underpinning depression
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting cyclooxygenase-2 in depression is not a viable therapeutic approach and may even aggravate the pathophysiology underpinning depression
Authors
Keywords
-
Journal
METABOLIC BRAIN DISEASE
Volume 27, Issue 4, Pages 405-413
Publisher
Springer Nature
Online
2012-07-06
DOI
10.1007/s11011-012-9326-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cyclooxygenase-1 null mice show reduced neuroinflammation in response to β-amyloid
- (2016) Sang-Ho Choi et al. Aging-US
- Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment
- (2014) Piotr Gałecki et al. Pharmacological Reports
- Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies
- (2012) Juan Antonio Avina-Zubieta et al. ANNALS OF THE RHEUMATIC DISEASES
- Cytoprotective effect of nonsteroidal antiinflammatory drugs in rat brain slices subjected to reoxygenation after oxygen–glucose deprivation
- (2012) Juan Antonio López-Villodres et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder
- (2012) Piotr Gałecki et al. JOURNAL OF AFFECTIVE DISORDERS
- The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance and therapeutic implications
- (2012) S Moylan et al. MOLECULAR PSYCHIATRY
- Extended results of the Alzheimer’s disease anti-inflammatory prevention trial
- (2011) John C. Breitner et al. Alzheimers & Dementia
- Effects of celecoxib in young rats: Histopathological changes in tissues and alterations of oxidative stress/antioxidant defense system
- (2011) Sumru Sozer et al. ARCHIVES OF PHARMACAL RESEARCH
- Celecoxib, a Selective Cyclooxygenase-2 Inhibitor, Attenuates Renal Injury in a Rat Model of Cisplatin-Induced Nephrotoxicity
- (2011) Ghada M. Suddek et al. CHEMOTHERAPY
- Inflammatory and Neurodegenerative Pathways in Depression: A New Avenue for Antidepressant Development?
- (2011) M. Catena-Dell'Osso et al. CURRENT MEDICINAL CHEMISTRY
- IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: New pathways that underpin the inflammatory and neuroprogressive pathophysiology
- (2011) Michael Maes et al. JOURNAL OF AFFECTIVE DISORDERS
- Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression
- (2011) Brian Leonard et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Activation of cell-mediated immunity in depression: Association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression
- (2011) Michael Maes et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Emotion Recollected in Tranquility: Lessons Learned from the COX-2 Saga
- (2010) Tilo Grosser et al. Annual Review of Medicine
- Targeting cyclooxygenases-1 and -2 in neuroinflammation: Therapeutic implications
- (2010) Saba Aïd et al. BIOCHIMIE
- Functional Polymorphism of Cyclooxygenase-2 Gene (G–765C) in Depressive Patients
- (2010) Piotr Gałecki et al. NEUROPSYCHOBIOLOGY
- Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors
- (2010) M. Berk et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Cytokines mediated inflammation and decreased neurogenesis in animal models of depression
- (2010) Cai Song et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Beyond the serotonin hypothesis: Mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders
- (2010) Ann Gardner et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness
- (2010) Michael Maes et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression
- (2010) Marta Kubera et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression
- (2010) Michael Maes PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- cPLA2 Is Protective Against COX Inhibitor–Induced Intestinal Damage
- (2010) David C. Montrose et al. TOXICOLOGICAL SCIENCES
- Astrocytic expression of Parkinson's disease-related A53T α-synuclein causes neurodegeneration in mice
- (2010) Xing-Long Gu et al. Molecular Brain
- A Meta-Analysis of Cytokines in Major Depression
- (2009) Yekta Dowlati et al. BIOLOGICAL PSYCHIATRY
- Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial
- (2009) Shahin Akhondzadeh et al. DEPRESSION AND ANXIETY
- Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients
- (2009) Piotr Gałecki et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Regionally-specific changes in levels of tumour necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorder
- (2009) Brian Dean et al. JOURNAL OF AFFECTIVE DISORDERS
- Cyclooxygenase-1 and -2 Differentially Modulate Lipopolysaccharide-Induced Blood–Brain Barrier Disruption through Matrix Metalloproteinase Activity
- (2009) Saba Aid et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis
- (2009) M Bryant Howren et al. PSYCHOSOMATIC MEDICINE
- Association of myocardial infarctions with COX-2 inhibition may be related to immunomodulation towards a Th1 response resulting in atheromatous plaque instability: an evidence-based interpretation
- (2009) I. T. Padol et al. RHEUMATOLOGY
- Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats
- (2008) D R H Huntjens et al. BRITISH JOURNAL OF PHARMACOLOGY
- COX-2 Inhibition in Schizophrenia and Major Depression
- (2008) Norbert Muller et al. CURRENT PHARMACEUTICAL DESIGN
- Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2
- (2008) Saba Aid et al. Journal of Neuroinflammation
- Cyclooxygenase 2-Selective and Nonselective Nonsteroidal Anti-Inflammatory Drugs Induce Oxidative Stress by Up-Regulating Vascular NADPH Oxidases
- (2008) H. Li et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil
- (2008) Bhupesh Sharma et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression
- (2008) Michael Maes et al. METABOLIC BRAIN DISEASE
- Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury
- (2007) Sang-Ho Choi et al. FASEB JOURNAL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started